Research Site

Clydebank G81 4DY

1 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, CKD, Cardiac Disease, Cardiopulmonary Bypass, Chronic Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Kidney Disease, Heart Failure, Heart Failure and Impaired Kidney Function, Pulmonary Hypertension (World Health Organization Group 2)

Studies at this site

• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function — Recruiting now
• ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE — Stopped early
• A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 — Completed
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure — Completed